

Our Partners
Our Partners
Impact through deep domain expertise.
Impact through deep domain expertise.

Aptahem
We are very pleased to announce that Jarlen Capital will be supporting Aptahem in identifying and engaging potential partners for its lead asset, Apta-1. We look forward to working closely with the Aptahem team to advance partnering discussions and support the continued development of Apta-1.


Aptahem
We are very pleased to announce that Jarlen Capital will be supporting Aptahem in identifying and engaging potential partners for its lead asset, Apta-1. We look forward to working closely with the Aptahem team to advance partnering discussions and support the continued development of Apta-1.

Aptahem
We are very pleased to announce that Jarlen Capital will be supporting Aptahem in identifying and engaging potential partners for its lead asset, Apta-1. We look forward to working closely with the Aptahem team to advance partnering discussions and support the continued development of Apta-1.

We do not just advise from the sidelines. We help build and run the BD pipeline, coordinate outreach around key catalysts, support negotiations and governance design, and keep internal stakeholders aligned on risks and trade-offs. With cross-border reach into relevant BD&L, corporate and investment teams, we plug you into the right rooms and ensure you show up prepared, consistent and credible.

UV Medico
Through this partnership, we support healthcare providers and high-risk environments with an innovative infection-prevention solution that helps protect patients, staff, and visitors. UV Medico’s approach aligns with our commitment to bringing practical, high-quality technologies to organisations seeking safer, cleaner, and more resilient spaces.


UV Medico
Through this partnership, we support healthcare providers and high-risk environments with an innovative infection-prevention solution that helps protect patients, staff, and visitors. UV Medico’s approach aligns with our commitment to bringing practical, high-quality technologies to organisations seeking safer, cleaner, and more resilient spaces.
We do not just advise from the sidelines. We help build and run the BD pipeline, coordinate outreach around key catalysts, support negotiations and governance design, and keep internal stakeholders aligned on risks and trade-offs. With cross-border reach into relevant BD&L, corporate and investment teams, we plug you into the right rooms and ensure you show up prepared, consistent and credible.

Sanyou Biopharmaceuticals
We’re appointed by Sanyou Biopharmaceuticals to represent its biologics discovery and development services in Europe, giving our biopharma network access to integrated capabilities across antibody discovery, AI-enabled R&D, and CRO/CDO/CPO support. We help accelerate innovative biologics programs with greater efficiency, quality, and confidence.


Sanyou Biopharmaceuticals
We’re appointed by Sanyou Biopharmaceuticals to represent its biologics discovery and development services in Europe, giving our biopharma network access to integrated capabilities across antibody discovery, AI-enabled R&D, and CRO/CDO/CPO support. We help accelerate innovative biologics programs with greater efficiency, quality, and confidence.
We do not just advise from the sidelines. We help build and run the BD pipeline, coordinate outreach around key catalysts, support negotiations and governance design, and keep internal stakeholders aligned on risks and trade-offs. With cross-border reach into relevant BD&L, corporate and investment teams, we plug you into the right rooms and ensure you show up prepared, consistent and credible.
How we can help
How we can help
More than a deal advisor, we’re your growth partner.
More than a deal advisor, we’re your growth partner.
Kristoffer Danielsson
Founder
Kristoffer Danielsson
Founder
Kristoffer Danielsson
Founder
01.
At what stage of development does it make sense to work with Jarlen Capital?
02.
Do you only work with biotech companies, or also with pharma and investors?
03.
How do you typically engage, project-based, ongoing support, or as an extended BD function?
04.
How is your work different from what a bank, broker, or generic consulting firm would do?
At what stage of development does it make sense to work with Jarlen Capital?
Do you only work with biotech companies, or also with pharma and investors?
How do you typically engage, project-based, ongoing support, or as an extended BD function?
How is your work different from what a bank, broker, or generic consulting firm would do?

We always strive for excellence
We connect visionary researchers and impact driven investors to shape the future of healthcare.

We always strive for excellence
We connect visionary researchers and impact driven investors to shape the future of healthcare.

We always strive for excellence
We connect visionary researchers and impact driven investors to shape the future of healthcare.
